abstract |
This invention concerns various methods of using radiolabeled HSP90 inhibitors to improve treatment of neurodegenerative disease patients with HSP90 inhibitors, includingex vivoandin vivomethods for determining whether a patient will likely respond to therapy with an HSP90 inhibitor. |